Biotech Startup Scout - Labiotech.eu

Home Startup Scout Page 9

Latest Posts

bionext drug development software2 1

Startup Scout 2 Feb 2018

This French Biotech’s Software Helps Drugs to Succeed in the Clinic

We’re in the French region of Alsace to visit BioNext, which develops software to help pharma and biotech companies to avoid pursuing flawed drug candidates. Mission: So far, BioNext has developed two tools that allow companies developing drugs to take a closer look at the target that they want to manipulate. Target Analysis identifies macromolecules that have specific interaction […]

February 2, 2018 - 1 minutemin - By Alex Dale

acesion pharma cardiac arrhythmia 1

Startup Scout 26 Jan 2018

This Danish Biotech is Working on Better, Safer Drugs for Cardiac Arrhythmia

This week, we’re visiting Acesion Pharma in Copenhagen, a biotech that is developing more effective, safer drugs for atrial fibrillation, the most common form of cardiac arrhythmia. Mission: Since being founded in 2011, Acesion has already caught our attention, being named as one of our top biotechs in Copenhagen. The biotech focuses on the development of […]

January 26, 2018 - 2 minutesmins - By Alex Dale

bioinova stem cell therapies 1

Startup Scout 15 Dec 2017

Czech this Biotech Out! Bioinova Develops Stem Cell Therapies

This week, we are in Prague to visit Bioinova. This biotech develops cell therapies for a wide range of indications, from broken bones to autoimmune diseases. Mission: From bone marrow and adipose (fat) tissue, Bioinova develops stem cell products that can be used for orthopedic, ophthalmological, neurological, and autoimmune indications, as well as to aid wound healing. […]

December 15, 2017 - 2 minutesmins - By Alex Dale

neurolixis cns disease france 1

Startup Scout 13 Oct 2017

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

This week we’re in Castres in the South of France to visit Neurolixis. This biotech is taking on diseases of the CNS, such as Parkinson’s, depression and schizophrenia. Mission: Neurolixis is tackling CNS and mood diseases, a number of which lack effective treatment options at the moment. The biotech currently has two candidate drugs undergoing […]

October 13, 2017 - 2 minutesmins - By Alex Dale

Cytovation biotech Norway Bergen

Startup Scout 7 Jul 2017

A Norwegian Biotech is Aiming at Permanently Removing HPV Skin Infections

This week we’re traveling to Bergen, a beautiful coastal city in Norway surrounded by seven mountains, where a biotech called Cytovation is developing a brand new treatment for benign tumors caused by the human papillomavirus. Mission: Cytovation is developing what could be the first prescription treatment for cutaneous warts, which are a form of […]

July 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Antag Therapeutics Startup Obesity

Startup Scout 30 Jun 2017

This Danish Biotech Thinks it Can Tackle the Obesity Epidemic

Apart from boasting big players in the space of metabolic diseases including Novo Nordisk and Zealand Pharma, Copenhagen is a hotspot for research on obesity and diabetes. This week we had a look at Copenhagen’s latest addition to the field, Antag Therapeutics. Mission: Antag Therapeutics is working on new treatments for the growing number of patients with obesity. […]

June 30, 2017 - 2 minutesmins - By Melanie De Almeida

ADVERTISEMENT

Osivax Imaxio Vaccines

Startup Scout 23 Jun 2017

This Newly Founded French Biotech is All About Vaccines

This week we visited the biotech hub Lyon, where one of our top biotechs Imaxio has recently founded Osivax to advance the development of its innovative vaccine candidates. Mission: Osivax was formed as a spin-off of Imaxio’s R&D department and develops a number of clinical and preclinical vaccine candidates based on its OligoDOM technology. This approach fuses specific immunogenic domains to […]

June 23, 2017 - 1 minutemin - By Melanie De Almeida

Oxthera hyperoxaluria oxabact

Startup Scout 16 Jun 2017

Meet the Swedish Biotech that is Set to Cure a Rare Kidney Disease

This week we visited the Scandinavian summer and had a look at the Swedish biotech Oxthera, which is developing cell- and enzyme-based therapies to treat hyperoxaluria. Mission: Stockholm-based Oxthera is currently advancing two late-stage clinical products for the treatment of primary and secondary hyperoxaluria, a kidney disease that is caused by the build-up of oxalate in plasma […]

June 16, 2017 - 2 minutesmins - By Melanie De Almeida

PDCline Pharma Immunotherapy melanoma

Startup Scout 2 Jun 2017

This French Biotech Wants to Reinvent DC-based Immunotherapies

This week we had the chance to visit both Grenoble and Liège, where the French-Belgian biotech hybrid PDC*line Pharma has its two headquarters. The company is progressing new types of immunotherapies based on dendritic cells (DCs). Mission: PDC*line Pharma emerged from an R&D program of the French Blood Bank (EFS, Etablissement Français du Sang), where […]

June 2, 2017 - 2 minutesmins - By Melanie De Almeida

Ntrans Technologies iTOP Delivery

Startup Scout 28 Apr 2017

This Dutch Biotech Could Boost Gene Editing of Primary Cells

Located in the charming town of Utrecht in the Netherlands, Ntrans Technologies was newly founded in 2015 based on a cutting-edge intracellular delivery technology developed at the Hubrecht Institute of the Royal Netherlands Academy of Sciences. Mission: NTrans is developing the iTOP technology for its use in research and as a therapeutical platform for the delivery of bioactive molecules into […]

April 28, 2017 - 2 minutesmins - By Melanie De Almeida

Prokarium Oral Vaccines

Startup Scout 21 Apr 2017

No more Needles – This UK Biotech is Developing Innovative Oral Vaccines

The small village of Keele is probably best known for its university, but it also hosts the Keele Science Park, where the biotech company Prokarium is developing new oral vaccine solutions based on synthetic biology. Mission: Prokarium has the vision that all protein vaccines can be delivered orally. Founded in 2012, the company has developed an oral […]

April 21, 2017 - 2 minutesmins - By Melanie De Almeida

PCI Biotech cancer norway

Startup Scout 14 Apr 2017

This Norwegian Biotech Aims to Unlock the Full Potential of Cancer Drugs

This week we visited the Norwegian PCI Biotech. Based in Oslo, this company has developed a light-sensitive technology, which allows to activate cancer drugs at specific sites of the body by targeted illumination. Mission: PCI Biotech focuses on the development of new therapies for the treatment of cancer based on its photochemical internalisation (PCI) technology. The PCI technology consists of a photosensitising […]

April 14, 2017 - 2 minutesmins - By Melanie De Almeida

ADVERTISEMENT